Apaf-1 expression in malignant melanoma

[1]  L. T. Peltenburg,et al.  Expression and function of the apoptosis effector Apaf-1 in melanoma , 2005, Cell Death and Differentiation.

[2]  A. Strasser,et al.  Is Apaf-1 expression frequently abrogated in melanoma? , 2005, Cell Death and Differentiation.

[3]  T. Mak,et al.  Specific Ablation of the Apoptotic Functions of Cytochrome c Reveals a Differential Requirement for Cytochrome c and Apaf-1 in Apoptosis , 2005, Cell.

[4]  H. Pilch,et al.  Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia. , 2005, Gynecologic oncology.

[5]  David Loegering,et al.  Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel , 2004, Clinical Cancer Research.

[6]  A. Anichini,et al.  Apoptosis Protease Activator Protein-1 Expression Is Dispensable for Response of Human Melanoma Cells to Distinct Proapoptotic Agents , 2004, Cancer Research.

[7]  F. Prósper,et al.  Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. , 2004, Blood.

[8]  M. Martinka,et al.  Reduced Apaf-1 expression in human cutaneous melanomas , 2004, British Journal of Cancer.

[9]  D. Elashoff,et al.  Allelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome , 2004, Cancer Research.

[10]  D. Elashoff,et al.  Allelic Imbalance of 12q22–23 Associated with APAF-1 Locus Correlates with Poor Disease Outcome in Cutaneous Melanoma , 2004, Cancer Research.

[11]  G. Botti,et al.  Analysis of APAF‐1 expression in human cutaneous melanoma progression , 2004, Experimental dermatology.

[12]  T. Mak,et al.  Coupling of caspase‐9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell‐type‐specific , 2004, The EMBO journal.

[13]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[14]  L. T. Peltenburg,et al.  A serine protease is involved in the initiation of DNA damage-induced apoptosis , 2003, Cell Death and Differentiation.

[15]  O. Tachibana,et al.  Frequent LOH at Chromosome 12q22‐23 and Apaf‐1 Inactivation in Glioblastoma , 2003, Brain pathology.

[16]  S. Lowe,et al.  Apoptosis and melanoma chemoresistance , 2003, Oncogene.

[17]  L. Jia,et al.  Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemia , 2003, Oncogene.

[18]  H. Endo,et al.  Apaf-1 Is a Mediator of E2F-1-induced Apoptosis* , 2002, The Journal of Biological Chemistry.

[19]  David Polsky,et al.  Focus on melanoma. , 2002, Cancer cell.

[20]  Ximena Opitz-Araya,et al.  Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization , 2002, Science.

[21]  K. Helin,et al.  Apaf-1 is a transcriptional target for E2F and p53 , 2001, Nature Cell Biology.

[22]  W. Gerald,et al.  Inactivation of the apoptosis effector Apaf-1 in malignant melanoma , 2001, Nature.

[23]  Y. Lazebnik,et al.  Caspase-9 and APAF-1 form an active holoenzyme. , 1999, Genes & development.

[24]  S. Zerp,et al.  p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis , 1999, British Journal of Cancer.